AgeX Therapeutics Inc (AGE) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
AgeX has utilized $500,000 from its credit line provided by Juvenescence, with the repayment of the principal sum scheduled for May 9, 2024. This financial move and its conditions are detailed in AgeX’s recent Quarterly Report submitted to the SEC.
For further insights into AGE stock, check out TipRanks’ Stock Analysis page.
